Table 3

Three month treatment effect of doxycycline compared with placebo for chronic seronegative or reactive arthritis

Doxycycline (n=16)Placebo (n=21)Comparison
0 m3 mChange0 m3 mChangeMean difference (95% CI)p3-150
AIMS23-151pain10.813.52.712.713.81.11.5 (−1.2 to 4.2)0.25
AIMS2 function3-152 (4 scales)71.975.13.273.075.42.40.8 (−5.6 to 7.1)0.81
AIMS2 mobility21.522.10.621.121.70.60.0 (−3.2 to 3.1)0.97
AIMS2 walking and bending13.216.33.215.116.61.61.6 (−0.9 to 4.2)0.21
AIMS2 self care18.919.40.619.119.20.20.4 (−1.1 to 1.8)0.61
AIMS2 household tasks18.417.3−1.117.917.90.0−1.2 (−3.0 to 0.6)0.19
AIMS2 hand and finger11.110.5−0.68.88.2−0.60.0 (−2.3 to 2.2)0.97
AIMS2 arm10.99.1−1.97.46.8−0.6−1.3 (−3.0 to 0.5)0.15
AIMS2 mood18.519.20.719.020.01.0−0.3 (−2.0 to 1.4)0.72
AIMS2 tension14.815.30.516.217.61.4−0.9 (−3.0 to 1.2)0.38
AIMS2 family and friends6.87.40.67.28.51.3−0.7 (−2.6 to 1.1)0.41
AIMS2 social activity15.615.5−0.116.516.50.0−0.1 (−2.7 to 2.6)0.96
AIMS2 work12.212.20.014.917.42.5−2.5 (−5.4 to 0.5)0.10
Joint count4.05.61.65.45.50.11.6 (−1.6 to 4.7)0.32
Pain score (VAS3-153)4.34.60.33.64.50.9−0.6 (−3.1 to 1.9)0.46
Functional score (VAS)4.03.7−0.32.22.80.7−0.9 (−2.5 to 0.7)0.15
Arthritis activity (VAS)4.54.70.13.64.40.8−0.6 (−3.1, 1.9)0.48
  • 3-150 Change score means compared by unpairedt test (SPSS).

  • 3-151 AIMS2 = Arthritis Impact Measurement Scales version 2 self assessed questionnaire (n=37). Lower numbers indicate a worse score. AIMS2 pain and composite functional scores constituted the primary study end points.

  • 3-152 Composite functional score consists of sum of mobility, walking and bending, self care, and household tasks AIMS2 scales.

  • 3-153 VAS = visual analogue scale (0 = best, 10 = worst) assessed by rheumatologist (n=25).